About Vins Bioproducts Limited
Data last updated: 16 February 2026
Vins Bioproducts Limited is a public limited company based in Maheswaram, Telangana, India. It specialises in drug formulation and development, a part of the broader pharmaceuticals sector. Incorporated on 17 February 1997, the company has been in operation for over 29 years.
Registered with ROC Hyderabad under CIN U24110AP1997PTC026437.
Capital: an authorised share capital of ₹20 Cr and a paid-up capital of ₹20 Cr. Formerly known as Vins Bioproducts Private Limited. It is led by directors including Balkishan Badruka and Shreedas Narayandas Daga.
Last AGM: 30 September 2025. Financial statements filed for year ended 31 March 2025. Office: Maheswaram, Telangana.
As per the financials filed for FY 2025, the company reported a revenue of ₹210.48 Cr, a growth of 34% compared to the previous year.
The company is associated with 1 brand - Vins Bio Products. As per MCA filings, the company has open charges of ₹25.66 Cr and satisfied charges of ₹5.46 Cr on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website vinsbio.in.
-
Email**************
-
Telephone**************
-
Website**************
-
Social Media**************
-
Registered AddressSy. No. 117 Thimmapur Village, Kothur Mandal, Maheswaram, Telangana, India – 509325
-
IndustryPharma, Drug Formulation & Development
- Historical Financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Litigation, compliance and MCA filings
- PDF report delivered after checkout
CIN History of Vins Bioproducts Limited
Vins Bioproducts Limited has 2 previous CINs, indicating changes in the company's corporate structure or registration details. The current CIN is U24110TG1997PLC026437, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24110TG1997PLC026437 | Current |
| U24110AP1997PTC026437 | Previous |
| U24110AP1997PLC026437 | Previous |
Associated Brands with Vins Bioproducts Limited
Vins Bioproducts Limited operates one associated brand: Vins Bio Products. These brands represent Vins Bioproducts Limited's diversified market presence and brand portfolio.
| Brand | Description | Website |
|---|---|---|
| Antisera and antitoxins for snake bites and infections are developed. | vinsbio.in |
Competitors & Alternatives of Vins Bioproducts Limited
Brands and companies operating in the same space as Vins Bioproducts Limited include Vaxcyte, Serum Institute of India, Biological E and 7 more.
| Competitor | Description | Location | Founded |
|---|---|---|---|
|
|
Vaccines for infectious diseases are developed using cell-free protein synthesis. | Foster City, United States, United States | 2013 |
|
|
Vaccines and immuno-biological drugs for infectious diseases are manufactured. | Pune, India, India | 1966 |
|
|
Vaccines and therapeutics for multiple diseases are developed and marketed. | Hyderabad, India, India | 1953 |
|
|
Developer of therapeutics for the treatment of gastrointestinal and infectious diseases | Ramat Gan, Israel, Israel | 2009 |
|
|
Prophylactic vaccines for infectious diseases are developed and advanced. | Lyon, France, France | 1999 |
|
|
Gene therapy platform is developed for chronic disease treatments. | Stevenage, United Kingdom, United Kingdom | 2015 |
|
|
Developer of therapeutics for the treatment of infectious diseases | San Francisco, United States, United States | 2017 |
|
|
Novel anti-infectives for bacterial and fungal infections are developed. | San Diego, United States, United States | 2013 |
|
|
Vaccines against mutating pathogens are developed using nanoparticle technology. | Lyon, France, France | 2017 |
|
|
AAV-based gene therapies for rare diseases are developed. | Durham, United States, United States | 2015 |
Business Activity of Vins Bioproducts Limited
Vins Bioproducts Limited is engaged in the principal business activity of manufacturing, with detailed activities including chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | ********* |
Board of Directors of Vins Bioproducts Limited
Vins Bioproducts Limited is currently managed by 8 directors, with 16 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
|
Balkishan Badruka
Also directs:
Vins Lifesciences Private Limited, Badruka Exim Pvt Ltd
|
Director | 30 Aug 2017 | 8 Years 10 Months | Current |
| Shreedas Narayandas Daga | Whole-Time Director | 01 Aug 2011 | 14 Years 11 Months | Current |
|
Sunaina Bihani
Also directs:
Essjay Gardens Llp, Redemption Bungalow Hospitality Private Limited, Isha Buildcon Llp and 5 more
|
Director | 18 Jun 2021 | 5 Years 0 Months | Current |
| Varun Jain | Director | 13 Jun 2024 | 2 Years 0 Months | Current |
| Siddarth Daga | Managing Director | 01 Apr 2013 | 13 Years 3 Months | Current |
Financials of Vins Bioproducts Limited FY 2025 filings available
Vins Bioproducts Limited reported revenue of ₹210.48 Cr (up 34% YoY) for FY 2025. Profit growth despite declining revenue indicates effective cost management and margin discipline.
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue from Operations | ***** | ***** | ***** | ***** | ***** |
| Revenue Growth % | ***** | ***** | ***** | ***** | ***** |
| Other Income | ***** | ***** | ***** | ***** | ***** |
| Total Revenue | ***** | ***** | ***** | ***** | ***** |
| Expenses | |||||
| Total Expenses | ***** | ***** | ***** | ***** | ***** |
| Raw Material Cost | ***** | ***** | ***** | ***** | ***** |
| Change in Inventory FG | ***** | ***** | ***** | ***** | ***** |
| Change in Inventory WIP | ***** | ***** | ***** | ***** | ***** |
| Purchase of Traded Goods | ***** | ***** | ***** | ***** | ***** |
| Employee Cost | ***** | ***** | ***** | ***** | ***** |
| Managerial Remuneration | ***** | ***** | ***** | ***** | ***** |
| Audit Fees | ***** | ***** | ***** | ***** | ***** |
| Insurance | ***** | ***** | ***** | ***** | ***** |
| Power & Fuel | ***** | ***** | ***** | ***** | ***** |
| Interest | ***** | ***** | ***** | ***** | ***** |
| Depreciation | ***** | ***** | ***** | ***** | ***** |
| Other Expenses | ***** | ***** | ***** | ***** | ***** |
| Profitability | |||||
| EBITDA (Operating Profit) | ***** | ***** | ***** | ***** | ***** |
| Operating Margin % | ***** | ***** | ***** | ***** | ***** |
| Exceptional Items | ***** | ***** | ***** | ***** | ***** |
| Extraordinary Items | ***** | ***** | ***** | ***** | ***** |
| Profit Before Exceptional & Extraordinary Items | ***** | ***** | ***** | ***** | ***** |
| Profit Before Tax | ***** | ***** | ***** | ***** | ***** |
| Tax & Net Profit | |||||
| Tax Expense | ***** | ***** | ***** | ***** | ***** |
| Current Tax | ***** | ***** | ***** | ***** | ***** |
| Deferred Tax | ***** | ***** | ***** | ***** | ***** |
| Profit from Discontinued Operations | ***** | ***** | ***** | ***** | ***** |
| Tax on Discontinued Operations | ***** | ***** | ***** | ***** | ***** |
| Profit | ***** | ***** | ***** | ***** | ***** |
| Net Margin % | ***** | ***** | ***** | ***** | ***** |
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Shareholders' Funds | |||||
| Total Shareholders' Funds | ***** | ***** | ***** | ***** | ***** |
| Equity Capital | ***** | ***** | ***** | ***** | ***** |
| Reserves & Surplus | ***** | ***** | ***** | ***** | ***** |
| Money Against Warrants | ***** | ***** | ***** | ***** | ***** |
| Other Equity | ***** | ***** | ***** | ***** | ***** |
| Non-Current Liabilities | |||||
| Total Non-Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Long-Term Borrowings | ***** | ***** | ***** | ***** | ***** |
| Deferred Tax Liabilities | ***** | ***** | ***** | ***** | ***** |
| Other Non-Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Long-Term Provisions | ***** | ***** | ***** | ***** | ***** |
| Current Liabilities | |||||
| Total Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Short-Term Borrowings | ***** | ***** | ***** | ***** | ***** |
| Trade Payables | ***** | ***** | ***** | ***** | ***** |
| Other Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Short-Term Provisions | ***** | ***** | ***** | ***** | ***** |
| Total Equity & Liabilities | ***** | ***** | ***** | ***** | ***** |
| Non-Current Assets | |||||
| Non-Current Assets | ***** | ***** | ***** | ***** | ***** |
| Tangible Assets | ***** | ***** | ***** | ***** | ***** |
| Intangible Assets | ***** | ***** | ***** | ***** | ***** |
| Capital WIP | ***** | ***** | ***** | ***** | ***** |
| Intangibles Under Dev | ***** | ***** | ***** | ***** | ***** |
| Investments | ***** | ***** | ***** | ***** | ***** |
| Deferred Tax Assets | ***** | ***** | ***** | ***** | ***** |
| LT Loans & Advances | ***** | ***** | ***** | ***** | ***** |
| Other Non-Current Assets | ***** | ***** | ***** | ***** | ***** |
| Current Assets | |||||
| Current Assets | ***** | ***** | ***** | ***** | ***** |
| Current Investments | ***** | ***** | ***** | ***** | ***** |
| Inventories | ***** | ***** | ***** | ***** | ***** |
| Trade Receivables | ***** | ***** | ***** | ***** | ***** |
| Cash & Bank Balance | ***** | ***** | ***** | ***** | ***** |
| ST Loans & Advances | ***** | ***** | ***** | ***** | ***** |
| Other Current Assets | ***** | ***** | ***** | ***** | ***** |
| Total Assets | ***** | ***** | ***** | ***** | ***** |
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Cash from Operating Activities (CFO) | |||||
| Profit Before Tax | ***** | ***** | ***** | ***** | ***** |
| Non-Cash Adjustments | ***** | ***** | ***** | ***** | ***** |
| + Interest Expense | ***** | ***** | ***** | ***** | ***** |
| + Depreciation | ***** | ***** | ***** | ***** | ***** |
| +/- Unrealized Forex | ***** | ***** | ***** | ***** | ***** |
| - Dividend Income | ***** | ***** | ***** | ***** | ***** |
| - Interest Income | ***** | ***** | ***** | ***** | ***** |
| +/- Other Non-Cash Items | ***** | ***** | ***** | ***** | ***** |
| Changes in Working Capital | ***** | ***** | ***** | ***** | ***** |
| +/- Inventory | ***** | ***** | ***** | ***** | ***** |
| +/- Debtors | ***** | ***** | ***** | ***** | ***** |
| +/- Creditors | ***** | ***** | ***** | ***** | ***** |
| Reconciliation Adjustments | ***** | ***** | ***** | ***** | ***** |
| Cash Generated from Operations | ***** | ***** | ***** | ***** | ***** |
| Income Taxes Paid | ***** | ***** | ***** | ***** | ***** |
| Net CFO (Cash from Operations) | ***** | ***** | ***** | ***** | ***** |
| Cash from Investing Activities (CFI) | |||||
| Acquisitions & Disposals | ***** | ***** | ***** | ***** | ***** |
| Disposal of Subsidiaries | ***** | ***** | ***** | ***** | ***** |
| Acquisition of Subsidiaries | ***** | ***** | ***** | ***** | ***** |
| Capex | ***** | ***** | ***** | ***** | ***** |
| Purchase of Fixed Assets | ***** | ***** | ***** | ***** | ***** |
| Sale of Fixed Assets | ***** | ***** | ***** | ***** | ***** |
| Other Investing Cash Flows | ***** | ***** | ***** | ***** | ***** |
| Net CFI (Cash from Investing) | ***** | ***** | ***** | ***** | ***** |
| Cash from Financing Activities (CFF) | |||||
| Equity Issuance | ***** | ***** | ***** | ***** | ***** |
| Debt Raised | ***** | ***** | ***** | ***** | ***** |
| Debt Repaid | ***** | ***** | ***** | ***** | ***** |
| Dividends Paid | ***** | ***** | ***** | ***** | ***** |
| Interest Paid | ***** | ***** | ***** | ***** | ***** |
| Net CFF (Cash from Financing) | ***** | ***** | ***** | ***** | ***** |
| Net Cash Position | |||||
| Net Change in Cash (Pre-Forex) | ***** | ***** | ***** | ***** | ***** |
| Closing Cash & Equivalents | ***** | ***** | ***** | ***** | ***** |
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Liquidity | |||||
| Current Ratio | ***** | ***** | ***** | ***** | ***** |
| Quick Ratio | ***** | ***** | ***** | ***** | ***** |
| Cash Ratio | ***** | ***** | ***** | ***** | ***** |
| Efficiency | |||||
| Inventory Days | ***** | ***** | ***** | ***** | ***** |
| Debtor Days | ***** | ***** | ***** | ***** | ***** |
| Creditor Days | ***** | ***** | ***** | ***** | ***** |
| Cash Conversion Cycle | ***** | ***** | ***** | ***** | ***** |
| Asset Turnover | ***** | ***** | ***** | ***** | ***** |
| Profitability | |||||
| Net Profit Margin % | ***** | ***** | ***** | ***** | ***** |
| Operating Margin % | ***** | ***** | ***** | ***** | ***** |
| ROE % | ***** | ***** | ***** | ***** | ***** |
| ROCE % | ***** | ***** | ***** | ***** | ***** |
| Net Worth Margin % | ***** | ***** | ***** | ***** | ***** |
| Growth | |||||
| Revenue Growth % | ***** | ***** | ***** | ***** | ***** |
| Leverage | |||||
| Equity Multiplier | ***** | ***** | ***** | ***** | ***** |
| Debt / EBITDA | ***** | ***** | ***** | ***** | ***** |
| Solvency | |||||
| D/E Ratio | ***** | ***** | ***** | ***** | ***** |
| ICR | ***** | ***** | ***** | ***** | ***** |
Consolidated Statements
Income Statement, Balance Sheet, Cash Flow & Ratios available in the full report.
Charges & Borrowings of Vins Bioproducts Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 06 May 2024 | Others | ₹12.13 Lakh | Open |
| 06 Jan 2021 | Hdfc Bank Limited | ₹1.21 Cr | Open |
| 17 Jul 2018 | Hdfc Bank Limited | ₹14 Cr | Open |
| 09 Jun 2014 | Citi Bank N.A. | ₹32.45 Lakh | Open |
| 18 Aug 2004 | Canara Bank | ₹10 Cr | Open |
Total charge records: 12 View all charges
Employees and EPFO Compliance at Vins Bioproducts Limited
View historical data on people associated with Vins Bioproducts Limited, including employment history and EPFO contributions.
Employee Count & EPFO Data of Vins Bioproducts Limited
Access employee headcount trends, monthly PF payment records, EPFO establishment details, and compliance data.
GST Compliance of Vins Bioproducts Limited
GSTIN & GST Filing Data of Vins Bioproducts Limited
Access GSTIN registrations, state-wise filing compliance, HSN/SAC codes, and detailed goods & services data.
Credit Ratings, Litigation & Regulatory Alerts for Vins Bioproducts Limited
Credit Ratings, Legal Cases & Regulatory Alerts of Vins Bioproducts Limited
Access complete credit rating history, litigation records, regulatory alerts, and compliance data.
MSME Payment Delays by Vins Bioproducts Limited
MSME Payment Delays by Vins Bioproducts Limited
Track payments outstanding to micro and small enterprise vendors, as disclosed in half-yearly MSME-1 returns filed with the MCA.
Subsidiaries & Group Companies of Vins Bioproducts Limited
Subsidiaries & Group Companies of Vins Bioproducts Limited
See the full corporate group - holding company, subsidiaries, associates and joint ventures of Vins Bioproducts Limited with ownership details.
MCA Filings & Documents of Vins Bioproducts Limited
MCA Filings & Documents of Vins Bioproducts Limited
Download official documents filed with the Ministry of Corporate Affairs - from incorporation papers to the latest annual filings.
Recent Activity on Vins Bioproducts Limited
Frequently Asked Questions about Vins Bioproducts Limited
Vins Bioproducts Limited is an active public limited company in the pharma sector based in Maheswaram, Telangana, India. It was incorporated on 17 February 1997 (29+ years old) and is registered under CIN U24110TG1997PLC026437.
Vins Bioproducts Limited reported revenue of ₹210.48 Cr for FY 2025 (up 34.00% YoY).
The current directors of Vins Bioproducts Limited are:
- Balkishan Badruka
- Aayushi Jain
- Shreedas Narayandas Daga
- Sunaina Bihani
- Varun Jain
- Siddarth Daga
- Khusboo Mundra
- Siddarth Daga
The primary industry of Vins Bioproducts Limited is pharma. The company specifically operates in drug formulation and development. The company is currently active in this sector.
Vins Bioproducts Limited can be reached at the registered office: Sy. No. 117 Thimmapur Village, Kothur Mandal, Maheswaram, Telangana, India – 509325, or through the website vinsbio.in.
The authorised capital is ₹20 Cr, and the paid-up capital is ₹20 Cr.